Immunic Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Daniel Vitt
Chief executive officer
US$2.6m
Total compensation
CEO salary percentage | 20.3% |
CEO tenure | 5yrs |
CEO ownership | 0.4% |
Management average tenure | 4yrs |
Board average tenure | 3.9yrs |
Recent management updates
Recent updates
Here's Why We're A Bit Worried About Immunic's (NASDAQ:IMUX) Cash Burn Situation
Jan 22Here's Why Immunic (NASDAQ:IMUX) Must Use Its Cash Wisely
Oct 13Will Immunic (NASDAQ:IMUX) Spend Its Cash Wisely?
Jun 27Immunic sinks ~74% after hours as phase 1b psoriasis trial fails to separate from placebo
Oct 20Immunic stock gains on $60M oversubscribed PIPE financing
Oct 10Immunic GAAP EPS of -$0.72 in-line
Aug 04Here's Why Immunic (NASDAQ:IMUX) Must Use Its Cash Wisely
Jul 27Is Immunic (NASDAQ:IMUX) In A Good Position To Invest In Growth?
Apr 13Is Immunic (NASDAQ:IMUX) In A Good Position To Invest In Growth?
Dec 24Here's Why We're Watching Immunic's (NASDAQ:IMUX) Cash Burn Situation
Aug 13We're Hopeful That Immunic (NASDAQ:IMUX) Will Use Its Cash Wisely
May 10Immunic EPS misses by $0.95
May 06Immunic EPS misses by $0.07
Nov 05Enrollment underway in Immunic's Phase 2 part of IMU-838 study in COVID-19
Nov 02Immunic (IMUX) Investor Presentation - Slideshow
Oct 31CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | n/a | n/a | -US$94m |
Sep 30 2023 | n/a | n/a | -US$129m |
Jun 30 2023 | n/a | n/a | -US$127m |
Mar 31 2023 | n/a | n/a | -US$125m |
Dec 31 2022 | US$3m | US$520k | -US$120m |
Sep 30 2022 | n/a | n/a | -US$85m |
Jun 30 2022 | n/a | n/a | -US$83m |
Mar 31 2022 | n/a | n/a | -US$79m |
Dec 31 2021 | US$2m | US$399k | -US$93m |
Sep 30 2021 | n/a | n/a | -US$83m |
Jun 30 2021 | n/a | n/a | -US$77m |
Mar 31 2021 | n/a | n/a | -US$70m |
Dec 31 2020 | US$1m | US$381k | -US$44m |
Sep 30 2020 | n/a | n/a | -US$41m |
Jun 30 2020 | n/a | n/a | -US$36m |
Mar 31 2020 | n/a | n/a | -US$39m |
Dec 31 2019 | US$2m | US$202k | -US$35m |
Compensation vs Market: Daniel's total compensation ($USD2.56M) is above average for companies of similar size in the US market ($USD667.11K).
Compensation vs Earnings: Daniel's compensation has increased whilst the company is unprofitable.
CEO
Daniel Vitt (55 yo)
5yrs
Tenure
US$2,557,171
Compensation
Dr. Daniel Vitt, PhD has been the Chief Executive Officer of Immunic, Inc. since April 2019 and also serves as its President. He is also managing director of Immunic Research GmbH in Halle (Saale). Dr. Vit...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Executive Chairman | 5.3yrs | US$1.07m | 0.025% $ 27.3k | |
CEO, President & Director | 5yrs | US$2.56m | 0.43% $ 484.7k | |
Chief Financial Officer | 4yrs | US$1.48m | 0.028% $ 31.6k | |
Chief Medical Officer | 7.7yrs | US$1.46m | 0.34% $ 378.6k | |
Chief Scientific Officer | 7.3yrs | no data | no data | |
Head of Investor Relations & Communications | no data | no data | no data | |
General Counsel | 2.8yrs | no data | no data | |
Chief Business Officer | 2.5yrs | no data | no data |
4.0yrs
Average Tenure
55yo
Average Age
Experienced Management: IMUX's management team is considered experienced (4 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Executive Chairman | 5.3yrs | US$1.07m | 0.025% $ 27.3k | |
CEO, President & Director | 5yrs | US$2.56m | 0.43% $ 484.7k | |
Lead Independent Director | 4.4yrs | US$86.12k | 0.012% $ 13.2k | |
Independent Director | 4.5yrs | US$76.12k | 0.012% $ 13.6k | |
Independent Director | 5yrs | US$78.62k | 0.11% $ 124.0k | |
Member of Scientific Medical Advisory Board | 3.4yrs | no data | no data | |
Member of Scientific Medical Advisory Board | 3.4yrs | no data | no data | |
Member of Scientific Medical Advisory Board | 3.4yrs | no data | no data | |
Independent Director | less than a year | no data | 0% $ 0 | |
Independent Director | 1.8yrs | US$125.87k | 0.0020% $ 2.2k |
3.9yrs
Average Tenure
56yo
Average Age
Experienced Board: IMUX's board of directors are considered experienced (3.9 years average tenure).